← FDA Drug Approvals (Drugs@FDA)
ESOMEPRAZOLE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2022-02-10
Drug application
- FDA Application #
ANDA215732- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESOMEPRAZOLE SODIUM
- Generic name
- Esomeprazole Sodium
- Active ingredients
- ESOMEPRAZOLE SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SLATE RUN PHARMA
- First approval
- 2022-02-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown